SIRT1 and systemic lupus erythematosus: In a RES-treated atherosclerosis-prone lupus mouse model, RES tends to increase mRNA levels of sirtuin 1, and decrease vascular endothelial growth factor and CX3CL1 (neurotactin ligand) mRNA in the hippocampus.